WO2009082793A1 - Evanescent cream comprising plant oils and process for producing the same - Google Patents
Evanescent cream comprising plant oils and process for producing the same Download PDFInfo
- Publication number
- WO2009082793A1 WO2009082793A1 PCT/BR2007/000371 BR2007000371W WO2009082793A1 WO 2009082793 A1 WO2009082793 A1 WO 2009082793A1 BR 2007000371 W BR2007000371 W BR 2007000371W WO 2009082793 A1 WO2009082793 A1 WO 2009082793A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fact
- cream
- group
- evanescent
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Definitions
- the present invention discloses an evanescent cream with hydrating properties comprising the active extracts of Bactris gasipaes H. B. K and/or Mauritia flexuosa and a process for production the evanescent cream.
- a cream is a topical preparation usually for application to the skin. They may be considered pharmaceutical products as even cosmetic creams are based on techniques developed by pharmacy and unmedicated creams are highly used in a variety of skin conditions (dermatoses).
- Creams are semi-solid emulsions (mixtures of oil and water). They are divided into two types: oil-in- water (O/W) creams which are composed of small droplets of oil dispersed in a continuous aqueous phase, and water-in-oil (W/O) creams which are composed of small droplets of water dispersed in a continuous oily phase.
- Creams are topic formulations made by emulsified fat with water from 30 to 60% that can be a vehicle to some active products at skin.
- Oil-in-water creams are more comfortable and cosmetically acceptable as they are less greasy and more easily washed off using water.
- Water-in-oil creams are more difficult to handle but many drugs which are incorporated into creams are hydrophobic and will be released more readily from a water-in-oil cream than an oil-in-water cream.
- Water-in-oil creams are also more moisturizing as they provide an oily barrier which reduces water loss from the stratum corneum, the outmost layer of the skin.
- An emulsion is a pharmaceutical formulation with milky /fatty consistency which has a disperse phase (discontinous phase), a dispersant phase (continuos phase) and a third component known as emulsifier agent.
- the emulsions must have the pH between 5,5 and 6,5, excluding the cationic emulsions that must have a pH between 3,5 to 4,5 (ANTUNES 2002).
- the aqueous phase solubilize components of the solutions, the oil phase can be any compound lipossoluble and the emulsifier agent can keep the stability of the emulsion (PRISTA, 1999).
- the creams can be used as a provision barrier to protect the skin, even a physical barrier as sunscreens, to aid the retention of moisture (especially water-in-oil creams, cleansing, emollient effects and as a vehicle for drug substances such as local anesthetics, anti-inflammatory (NSAID or corticosteroids), hormones, antibiotics, antifungal, among others.
- Evanescent Creams are a special class of creams that could deeply adjust skin oily mechanism, repairing epidermis and the derma network tissue. The ingredients of the cream are easily absorbed and skin looks more vivid with brightness and long-lasting moisturizing effect.
- Bactris gasipaes is a species of palm native to the tropical forests of the South and Central America. It is a palm which fruit is a drupe with an edible pulp surrounding the single seed, 4-6 cm long and 3-5 cm broad. The rind (epicarp) of this wild palm can be red, yellow, or orange when the fruit is ripe depending on the variety of the palm.
- B. gasipaes is well known by the native populations where it usually grows up, and they having been used for centuries as food. They frequently eat the fruit stewed in salted water. However, it may be peeled and dressed with salt and honey, used to make compotes and jellies, or also used to make flour and edible oil. Because of the huge importance of B. gasipaes for the native populations, there are numerous common names for this plant in several languages and many countries such as peach-palm or pewa, pejibaye, tembe, pupunheira, and pupunha.
- the Moriche Palm, Mauritia flexuosa also known as the lte Palm, buriti, or aguaje, is a palm tree. It grows in and near swamps and other wet areas in tropical South America.
- the Moriche Palm fruit is edible with a high vitamin C content and used to make juice, jam, ice cream, and a fermented "wine".
- An oil high in vitamin A is extracted from the pulp and is frequently used to treat burns because of its soothing qualities.
- This tree is important to several bird species, such as the Red-bellied Macaw, Sulphury Flycatcher and Moriche Oriole, which use it for nesting and food.
- the patent literature contains some documents disclosing cosmetic compositions and palm oils.
- the document US 6,911 ,211 discloses a pharmaceutical and cosmetic carrier comprising solidifying agent and hydrophobic solvent for treatment of disease or disorders of the skin.
- the composition or carrier are prepared by mixing 1-25% of a solidifying agent and 75-99% of a hydrophobic solvent, by weight, wherein at least one of them has a therapeutic or cosmetic benefits.
- the hydrophobic carrier is selected from the group comprising plant derived oils, including palm oils.
- compositions comprising an oil and a specific gelling compound, comprising at least five percent wax and oil. At least one of the oils present at this invention is chosen from hydrocarbon- based plant oils, including palm oils.
- US 6,344,205 discloses a composition comprising an oily phase and a particulate phase comprising at least one pulverulent compound. The oily phase comprise, among other, palm oils.
- the patent literature also contains some documents disclosing Mauhtia flexuosa and/or Bactris gasipaes.
- Document WO 06/120646 discloses cosmetic compositions comprising terpenone for alleviating the signs of skin ageing. Although it discloses the use of Mauritia flexuosa in one composition it does not associate its use to the antioxidant activity.
- the present invention differs from the prior art due to the fact that it is a cleansing composition, and not an anti- ageing cream, and the extract of Mauritia flexuosa is the main active of the composition, in an amount higher than previously described.
- Document WO 99/64029 discloses plant extracts from Bactris balanoidea useful in pharmaceutical compositions to treat several diseases such as diabetes, acquired immunodeficiency syndrome, influenza, common cold symptoms, pulmonary emphysema, bronchitis, poliomyelitis, macular degeneration, cancer, gingivitis, dermatitis, hair loss, hepatitis, genital herpes, papilloma, and asthma.
- the present invention differs from the prior art in that it does not disclose a cosmetic composition comprising oils extracted from Mauritia flexuosa and/or Bactris gasipaes as main active agents.
- the document Pl 0301420-7 discloses a formulation for murmuru soaps containing fat from palm oils plant extracts of Astrocaryum faranae, Astrocaryum boret and Astrocaryum murmuru species.
- Document WO 05/118759 discloses a cosmetic composition comprising palm extracts for the skin, wherein the palm extracts are olein or palm oil.
- the present invention differs from the prior art in that it does not disclose a cosmetic composition comprising oils extracted from Mauritia flexuosa and/or Bactris gasipaes as main active agents.
- a cream composition comprising: a) from 80% w/w to 97% w/w of emulsifiers; b) from 1% w/w to 3% w/w of a plant oil comprising oil from plants belonging to the genus Bactris and/or Mauritia; and c) from 2% w/w to 17% w/w of additional ingredients;
- It is a further objective of the invention a process for producing a cream composition comprising the steps of: a) preparing an oil phase comprising a plant oil comprising oil from plants belonging to the genus Bactris and/or Mauritia; b) preparing an aqueous phase comprising the surfactants; c) addition of the oil phase of a) in the aqueous phase of b) at a temperature higher than about 40 0 C; d) addition of the emulsion of c) into an adequate evanescent cream vehicle.
- the emulsion formed in step c) is formed by a Low Energy Emulsion process.
- the plant oils useful in the present invention are chosen from plants belonging to the genus Bactris and/or Mauritia.
- the plant oils are preferably extracted from the fruits, wherein the extraction process is according to the method for continuous extractions at controlled temperature and the extraction must be performed in the absence of light.
- the resulting oils were added in order to obtain only carotenoids, according to methods of the state of the art.
- the plants are Bactris gasipaes H. B. K. and/or Mauritia flexuosa, and are present in an amount of from 1% w/w to 3% w/w.
- One differential is the use of plant products, especially from the Amazon region, which imparts a greater absorption and penetration, leaving the skin smooth and with elasticity, protecting from free radicals.
- the cream base may be comprised of an emulsifier and/or an emollient and they may be present in an amount of from 80% w/w to 97% w/w.
- a mixture of an emulsifier and an emollient compose the base cream. Namely it is preferred a mixture of cetearyl alcohol and polyssorbate-60, also known as Polawax.
- Emollient refers to one or more liquids that soften or soothe the skin.
- An emollient material may be one or more generally hydrophobic materials (typically in liquid form) including, but not limited to, vaseline, mineral oils, animal and vegetable oils and fats, fatty acid esters derived from fatty acids or fatty alcohols, mixtures of hydrocarbon materials that resemble petrolatum in appearance and consistency.
- Suitable emollients include, without limitation, isopropyl miristate, fatty alcohols, such as cetostearyl alcohol.
- the surfactants (or emulsifier) useful in the present invention are chosen from the group comprising anionic, non-ionic, amphoteric and/or zwitterionic surfactants. Examples of each class are detailed below. a) Anionic Surfactants
- the anionic surfactant may comprise, wholly or predominantly, a C8-15 linear alkyl benzene sulphonate.
- Primary alkyl or alkenyl sulphate in which the alkyl or alkenyl chain has of 8 to 18 carbon atoms especially 10 to 14 carbon atoms and a solubilising cation, is also commercially significant as an anionic surfactant and may be used in this invention, olefin sulphonates; alkane sulphonates; dialkyl sulphosuccihates; and fatty acid ester sulphonates.
- One or more soaps of fatty acids may also be included.
- Examples are sodium soaps derived from the fatty acids from coconut oil, beef tallow, sunflower or hardened rapeseed oil. These may be formed by adding fatty acid and a base such as sodium carbonate to a mixture which is used to form the surfactant-rich base particles.
- a base such as sodium carbonate
- Nonionic surfactants that may be used include the primary and secondary alcohol ethoxylates, especially the C 8 -C 2O aliphatic alcohols ethoxylated with an average of from 1 to 20 moles of ethylene oxide per mole of alcohol, and more especially the Ci 0 -Ci 5 primary and secondary aliphatic alcohols ethoxylated with an average of from 1 to 10 moles of ethylene oxide per mole of alcohol.
- Non-ethoxylated nonionic surfactants include alkylpolyglycosides, glycerol monoethers, PEG-ylated sorbitan esterified with fatty acids and polyhydroxyamides (glucamide). c) Amphoteric and/or Zwitterionic Surfactants
- Preferred amphoteric surfactants are amine oxides. These are materials of the general formula:
- Ri is typically a C 8 -Ci 8 alkyl group, for example, Ci 2 -Ci 4 alkyl
- R 2 and R 3 which may be the same or different, are Ci-C 3 alkyl or hydroxyalkyl groups, for example, methyl groups.
- the most preferred amine oxide is coco dimethylamine oxide.
- Preferred zwitterionic surfactants are betaines, and especially amidobetaines.
- Preferred betaines are C 8 -Ci 8 alkyl amidoalkylbetaines, for example, coco amidopropyl betaine (CAPB).
- ingredients commonly used in the production of cleansing compositions can also be used in the present invention.
- these ingredients include, without limitation, humectants and/or moisturizers such as glycerin, opacifying agents such as glycol distearate, natural and/or synthetic polymers, silicones, volatile silicones, preservatives such as methylparaben and propylparaben, antioxidants, viscosity modifiers, fragrances and colorants.
- the colorants used in the cosmetic composition can be synthetic or natural, and are present in small amounts in the composition. They absorb visible light in a determined wavelength and send it in another, producing the observed coloration in the composition.
- Useful colorants include, without limitation, inorganic pigments, organic pigments and combinations thereof.
- Production Process Cream production processes useful in the present invention are those already part of the state of the art, such as the Continental Process. Also known as “method 4:2:1 , because for each four parts of oil, two parts of water and one part of gum is used in the production of the emulsion.
- the Arabic gum or any other O/W emulsifier is ground with the oil in a dry mortar until an homogeneous mixture is achieved. The best ratio between the oil, water and gum is 4:2:1.
- Cellulose derivatives or other emulsifiers can replace the gum.
- This method has two variants: a) Continental Direct: in this variant, the fatty material of the discontinuous phase (oil phase) is melted at 70°-90°C and then mixed with the continuous phase (aqueous phase). b) Continental Indirect: There is an inversion of phases, when one of the phases is higher than 74% (74% of aqueous phase and 26% of oil phase, or vice-versa)
- the use of the LEE method presents several advantages such as reduced use of thermal energy, substances and storage, producing a product with high viscosity, stability, consistency and appearance, when compared to classical production methods. It increases the yield up to 80% when compared with the continental process. Another advantage is the reduced emulsification cooling time and processing when compared to the state of the art methods.
- the LEE process comprises three different phases: oily, aqueous alpha
- the oil phase comprises the carotenoids and other fatty substances while the remaining ingredients are distributed in the fases alpha and beta.
- the present invention describes a method to produce an evanescent cream comprising ⁇ -carotene, present in the oil of Bactris gasipaes H. B. K. and Mauhtia flexuosa.
- the process comprise the steps of mixing phases A and B, followed by homogenization, and add this mixture to phase C at 50 0 C. After total homogenization, the vegetal oils are added and the formulation stored.
- the following table illustrates the components of phases A, B and C.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Cosmetics (AREA)
Abstract
Description
Claims
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0721323A BRPI0721323B1 (en) | 2007-12-28 | 2007-12-28 | evanescent cream comprising plant extracts, and process for the production thereof. |
| PCT/BR2007/000371 WO2009082793A1 (en) | 2007-12-28 | 2007-12-28 | Evanescent cream comprising plant oils and process for producing the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/BR2007/000371 WO2009082793A1 (en) | 2007-12-28 | 2007-12-28 | Evanescent cream comprising plant oils and process for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2009082793A1 true WO2009082793A1 (en) | 2009-07-09 |
Family
ID=40823711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/BR2007/000371 Ceased WO2009082793A1 (en) | 2007-12-28 | 2007-12-28 | Evanescent cream comprising plant oils and process for producing the same |
Country Status (2)
| Country | Link |
|---|---|
| BR (1) | BRPI0721323B1 (en) |
| WO (1) | WO2009082793A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015531380A (en) * | 2012-10-01 | 2015-11-02 | ナチュラ コスメティコス ソシエダッド アノニマ | Plant lipid composition for regulating the function of keratinous substances, method for regulating said function and use of said plant lipid |
| KR20240164069A (en) * | 2023-05-12 | 2024-11-19 | 조소영 | Aguahe extract with antioxidant, whitening, wrinkle improvement, and skin moisturizing functions and the cosmetic composition containing the same |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998048768A1 (en) * | 1997-05-01 | 1998-11-05 | Medlogic Global Corporation | Compositions for cosmetic applications |
| WO1998050005A1 (en) * | 1997-05-09 | 1998-11-12 | Medlogic Global Corporation | Compositions for cosmetic applications |
| JP2000319120A (en) * | 1999-05-10 | 2000-11-21 | Ichimaru Pharcos Co Ltd | Cosmetic composition including vegetable extract having moisture retaining property |
| WO2004084646A2 (en) * | 2003-03-27 | 2004-10-07 | Enzymotec Ltd. | Cosmetic compositions comprising phytosterol esters |
| US20050271595A1 (en) * | 2004-06-03 | 2005-12-08 | Brown James S | Sanitizing composition and method of preparation |
-
2007
- 2007-12-28 WO PCT/BR2007/000371 patent/WO2009082793A1/en not_active Ceased
- 2007-12-28 BR BRPI0721323A patent/BRPI0721323B1/en active IP Right Grant
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998048768A1 (en) * | 1997-05-01 | 1998-11-05 | Medlogic Global Corporation | Compositions for cosmetic applications |
| WO1998050005A1 (en) * | 1997-05-09 | 1998-11-12 | Medlogic Global Corporation | Compositions for cosmetic applications |
| JP2000319120A (en) * | 1999-05-10 | 2000-11-21 | Ichimaru Pharcos Co Ltd | Cosmetic composition including vegetable extract having moisture retaining property |
| WO2004084646A2 (en) * | 2003-03-27 | 2004-10-07 | Enzymotec Ltd. | Cosmetic compositions comprising phytosterol esters |
| US20050271595A1 (en) * | 2004-06-03 | 2005-12-08 | Brown James S | Sanitizing composition and method of preparation |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015531380A (en) * | 2012-10-01 | 2015-11-02 | ナチュラ コスメティコス ソシエダッド アノニマ | Plant lipid composition for regulating the function of keratinous substances, method for regulating said function and use of said plant lipid |
| KR20240164069A (en) * | 2023-05-12 | 2024-11-19 | 조소영 | Aguahe extract with antioxidant, whitening, wrinkle improvement, and skin moisturizing functions and the cosmetic composition containing the same |
| KR102816239B1 (en) | 2023-05-12 | 2025-06-02 | 조소영 | Aguahe extract with antioxidant, whitening, wrinkle improvement, and skin moisturizing functions and the cosmetic composition containing the same |
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0721323B1 (en) | 2015-09-08 |
| BRPI0721323A2 (en) | 2014-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111643376B (en) | Nanoemulsion composition and application thereof | |
| JP2005075817A (en) | O/w-type emulsion, method for producing the same, and external preparation for skin formed out of the same | |
| JP4335003B2 (en) | Ultrastable composition comprising wasabi oil and its derivatives and uses thereof | |
| EP2701671A1 (en) | Oil-in-water emulsion concentrate, method for producing same, and skin cosmetic containing said oil-in-water emulsion concentrate | |
| JP5219038B2 (en) | Skin keratinization promoter | |
| KR101448847B1 (en) | Cosmetic Composition Containing Ceramide For High Internal Phase Water-in-oil Type Emulsion and Method For Preparing Thereof | |
| JPH01176442A (en) | Oil-in-polyhydric alcohol type emulsified composition and oil-in-water type emulsified composition | |
| FR2918903A1 (en) | Multiple emulsion, useful e.g. in cosmetic composition, comprises internal and external aqueous or oil phase, intermediate oil or water phase and surfactant in water/oil interface, where oil phase and surfactant are of plant origin | |
| WO2009082793A1 (en) | Evanescent cream comprising plant oils and process for producing the same | |
| JP2010105925A (en) | Skin keratinization-promoting agent | |
| JP2013095717A (en) | Skin care external preparation, oil-in-water emulsion composition, and skin care external preparation containing the same | |
| RU2028795C1 (en) | Daytime cream for face skin | |
| WO2015064681A1 (en) | Composition for external use | |
| JP2015044780A (en) | Solubilizer | |
| JP6651223B2 (en) | Vesicle composition and hair cosmetic containing the same | |
| JP5641665B2 (en) | External preparation for skin and method for producing the same | |
| RU2236842C1 (en) | "diamant" cream for eyelids | |
| WO2009082790A1 (en) | Solid cleansing composition comprising oil from plants belonging to the genus bactris and/or mauritia | |
| WO2009082796A1 (en) | Cosmetic composition comprising plant extracts and preparation method of the same | |
| JP2001299890A (en) | Transparent gel composition containing terpenes | |
| RU2005471C1 (en) | Cream for face skin | |
| RU2008896C1 (en) | Cream for face skin | |
| JP2014129337A (en) | Moisturizing agent and external preparation including moisturizing agent | |
| RO107546B1 (en) | Cream for dry skin | |
| WO2009082791A1 (en) | Liquid composition comprising plant oil from plants belonging to the genus bactris and/or mauritia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07855388 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 07855388 Country of ref document: EP Kind code of ref document: A1 |
|
| REG | Reference to national code |
Ref country code: BR Ref legal event code: B01E Ref document number: PI0721323 Country of ref document: BR Free format text: COMPROVE QUE O SIGNATARIO DA PETICAO NO 020090077564 DE 13/08/2009 TEM PODERES PARA ATUAR EM NOME DO DEPOSITANTE, UMA VEZ QUE BASEADO NO ARTIGO 216 DA LPI, OS ATOS DEVEM SER PRATICADOS PELAS PARTES OU POR SEUS PROCURADORES, DEVIDAMENTE QUALIFICADOS. ADICIONALMENTE, APRESENTE DOCUMENTOS COMPROBATORIOS QUE EXPLIQUEM A DIVERGENCIA NO NOME DE UM DOS INVENTORES QUE CONSTA NA PUBLICACAO INTERNACIONAL WO2009/082793 DE 09/07/2009 "SONIA MARIA BRAGA DOS SANTOS" E O CONSTANTE DA PETICAO INICIAL NO 020090077564 DE 13/08/2009 "SONIA MARIA PATRICIO BRAGA DOS SANTOS". |
|
| REG | Reference to national code |
Ref country code: BR Ref legal event code: B01E Ref document number: PI0721323 Country of ref document: BR Free format text: EM ADITAMENTO A EXIGENCIA PUBLICADA NA RPI 2251 DE 25/02/2014, SOLICITA-SE QUE O DEPOSITANTE COMPROVE QUE O SIGNATARIO DA PETICAO NO 020090077564 DE 13/08/2009 TEM PODERES PARA ATUAR EM NOME DO DEPOSITANTE, UMA VEZ QUE NAO INFORMADO QUEM E O SIGNATARIO DO FOMULARIO 1.03. ADICIONALMENTE, A PRESENTE DOCUMENTOS COMPROBATORIOS QUE EXPLIQUEM A DIVERGENCIA NO NOME DE UM DOS INVENTORES QUE CONSTA NA PUBLICACAO INTERNACIONAL WO 2009/082793 DE 09/07/2009 "SONIA MARIA BRAGA DOS SANTOS" E O CONSTANTE DA PETICAO INICIAL NO 020090077564 DE 13/08/2009 "SONIA MARIA PATRICIO BRAGA DOS SANTOS". |
|
| ENP | Entry into the national phase |
Ref document number: PI0721323 Country of ref document: BR Kind code of ref document: A2 Effective date: 20090813 |